Jeffrey Walenta

Technology Transfer & Patent Specialist

Jeff Walenta joined the Agreement Coordination Group in the Regulatory Affairs Branch at CTEP NCI in June 2023. He is returning to the NIH after tenures as Senior Manager - Licensing, Business Development, and Ventures at the University of Colorado Anschutz Medical Campus and Technology Transfer Coordinator for the Plains Area at the USDA Agriculture Research Service. Jeff began his career in federal government in 2003 at the NIH Office of Technology Transfer as a Licensing and Patenting Manager in the Cancer and Biological Response Modifier Branch and followed as a Senior Monitoring and Enforcement Officer in the Monitoring and Enforcement Branch. He has negotiated and managed many agreements that support public-private partnerships to advance technologies, many with oncology focus, both inside and outside the government.

Prior to NIH OTT, Jeff had roles in research and development, process development, and manufacturing capacities at biotechnology companies in Maryland and Colorado focused on the use of synthetic DNA and RNA in therapeutic, diagnostic, imaging, and research use applications - one therapeutic is an FDA approved product. Prior to and concurrent with technology transfer roles, Jeff has worked with various organizations that support small companies to advance early-stage technologies.

Jeff has a Master's in Business Administration from Washington University in Saint Louis and a Bachelor of Science in Biology, with Genetics and Molecular Biology Emphasis, from the University of Maryland College Park.